NCT06915766 2026-03-09
Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis
Cogent Biosciences, Inc.
Available
Cogent Biosciences, Inc.
Karyopharm Therapeutics Inc
Orca Biosystems, Inc.